Ingo Pragst Selected Research

Ingo Pragst Research Topics

8	Hemorrhage 01/2021 - 10/2009
6	Angioedema 01/2022 - 01/2018
6	Hereditary Angioedemas 01/2022 - 01/2017
6	Thrombosis (Thrombus) 01/2021 - 08/2013
2	Pulmonary Embolism 04/2015 - 10/2009
2	Hemophilia A (Haemophilia) 07/2014 - 08/2013
2	Wounds and Injuries (Trauma) 02/2014 - 03/2010
1	Brain Ischemia (Cerebral Ischemia) 01/2016
1	Reperfusion Injury 01/2016
1	Stroke (Strokes) 01/2016
1	von Willebrand Diseases (von Willebrand's Disease) 07/2015
1	Venous Thromboembolism 02/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 07/2014
1	Hemophilia B (Haemophilia B) 05/2014
1	Acute Coronary Syndrome 09/2013
1	Atherosclerotic Plaque (Atheroma) 09/2013
1	Anaphylaxis (Anaphylactic Shock) 08/2013
1	Hypotension (Low Blood Pressure) 10/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2009
1	Hyperplasia 03/2002

3	Factor XII (Hageman Factor)IBA 01/2022 - 02/2014
3	Factor XIIa (Coagulation Factor XIIa)IBA 01/2022 - 01/2016
3	Prothrombin (Factor II)IBA 02/2015 - 03/2010
2	Fibrinogen (Factor I)FDA Link 01/2021 - 10/2009
2	recombinant FVIIa (rFVIIa)FDA Link 01/2021 - 03/2010
2	Factor VIII (Coagulation Factor VIII)IBA 07/2015 - 07/2014
2	von Willebrand FactorIBA 07/2015 - 07/2014
2	Peptide Hydrolases (Proteases)FDA Link 04/2015 - 02/2014
2	prothrombin drug combination factor X factor VII factor IXIBA 09/2014 - 03/2010
2	Thrombin FDA Link 07/2014 - 08/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	BradykininIBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2021
1	ferric chlorideIBA 01/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 04/2015
1	Factor VII (Proconvertin)IBA 04/2015
1	CollagenIBA 04/2015
1	Factor Xa InhibitorsIBA 02/2015
1	edoxabanIBA 02/2015
1	AntithrombinsIBA 09/2014
1	Dabigatran FDA Link 09/2014
1	AlbuminsIBA 05/2014
1	Recombinant Fusion ProteinsIBA 05/2014
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 05/2014
1	Hemostatics (Antihemorrhagics)IBA 02/2014
1	FibrinIBA 02/2014
1	A-factor (Streptomyces)IBA 02/2014
1	Neutralizing AntibodiesIBA 02/2014
1	AnticoagulantsIBA 02/2014
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	CholesterolIBA 09/2013
1	HDL LipoproteinsIBA 09/2013
1	CSL112IBA 09/2013
1	recombinant factor VIII SQIBA 08/2013
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 08/2013

7	Therapeutics 01/2022 - 09/2013
1	Anticoagulation Reversal 01/2021
1	Polypharmacy 01/2020
1	Extracorporeal Membrane Oxygenation 01/2016
1	Orthopedic Procedures 02/2015
1	Extracorporeal Circulation 02/2014
1	Surgical Instruments (Clip) 08/2013
1	Nephrotomy 03/2010
1	Resuscitation 03/2010
1	Photochemotherapy (Photodynamic Therapy) 03/2002